Intervening in global markets to improve access to HIV/AIDS treatment: an analysis of international policies and the dynamics of global antiretroviral medicines markets
Open Access
- 1 January 2010
- journal article
- Published by Springer Nature in Globalization and Health
- Vol. 6 (1) , 9
- https://doi.org/10.1186/1744-8603-6-9
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Factors influencing global antiretroviral procurement pricesBMC Public Health, 2009
- Global strategies to reduce the price of antiretroviral medicines: evidence from transactional databasesBulletin of the World Health Organization, 2009
- A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nationsAntiviral Research, 2008
- Sustaining access to antiretroviral therapy in the less-developed world: lessons from Brazil and ThailandAIDS, 2007
- Use of antiretroviral therapy in resource-limited countries in 2006: distribution and uptake of first- and second-line regimensAIDS, 2007
- HIV/AIDS Drugs for Sub-Saharan Africa: How Do Brand and Generic Supply Compare?PLOS ONE, 2007
- Generic fixed-dose combination antiretroviral treatment in resource-poor settings: multicentric observational cohortAIDS, 2006
- Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trialThe Lancet, 2004
- Scaling up antiretroviral therapy in resource-limited settings: guidelines for a public health approach. Executive summary. April 2002.2002
- Fixed-Dose Combinations of Antituberculous Medications To Prevent Drug ResistanceAnnals of Internal Medicine, 1995